Teva Investigational Site 29 — Dallas, Texas

Teva Investigational Site 29 is a clinical research site located in Dallas, Texas, United States 75231.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Teva Investigational Site 29 has participated in 2 clinical trials.

Therapeutic areas: Systemic Lupus Erythematosus.

Sponsors: Cephalon, Inc..

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 29?

Teva Investigational Site 29 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 29 conducted?

Teva Investigational Site 29 has 2 clinical trials on record. Their work covers Systemic Lupus Erythematosus.

Is Teva Investigational Site 29 accredited by Crixeo Health?

Teva Investigational Site 29 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 29?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.